Universal Health Services Inc (UHS) stock analysis
Close on Nov 12, 2026Market cap $11.42BP/E 8.1Yield 0.41%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid21 of 30 checks passed
Universal Health Services passes 21 of the 30 checks behind our score; 1 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 6/6
- Growth
- 2/6
- Past performance
- 6/6
- Financial health
- 3/6
- Dividend
- 4/6
What stands out
Margin of safety over 20%
The price is 40.9% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $196.77 is below our fair value estimate of $333.12.
Return on equity over 15%
Return on equity was 19.8% over the last twelve months and averaged 15.7% over five years.
Return on capital over 10%
Return on invested capital was 12.2%, above the 10% that usually covers the cost of capital.
What to watch
High debt
Debt is 75.1% of shareholders' equity, above the 40% we consider low.
Revenue growing under 10% a year
Revenue grew 9.0% a year over the last three fiscal years, short of the 10% we look for.
Earnings growth not accelerating
Net income grew 6.3% over the last twelve months, against a 5-year average of 9.5% a year.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.25; above 3 is the safe zone and below 1.8 the distress zone.
Valuation6/6
P/E below its 5-year median
Universal Health Services's P/E of 8.2 is below its own 5-year median of 11.4.
P/E below the industry
Universal Health Services's P/E of 8.2 is below the Health Services median of 23.9.
EV/EBITDA below its 5-year median
Universal Health Services's EV/EBITDA of 6.5 is below its 5-year median of 8.0.
P/B below the industry
Universal Health Services's price-to-book of 1.53 is below the Health Services median of 3.52.
Trading below fair value
The share price of $196.77 is below our fair value estimate of $333.12.
Margin of safety over 20%
The price is 40.9% below fair value, more than the 20% cushion we look for.
Growth2/6
Revenue growing under 10% a year
Revenue grew 9.0% a year over the last three fiscal years, short of the 10% we look for.
EPS growing 10%+ a year
Diluted EPS grew 36.2% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew 6.3% over the last twelve months, against a 5-year average of 9.5% a year.
Growing faster than the industry
Revenue grew 8.0% over the last twelve months; the Health Services median is 4.0%.
Guidance lowered
Universal Health Services lowered its Year Ended December 31, 2026 Adjusted EPS – diluted outlook on Jul 28, 2026.
Gross margin trend
This company does not report gross profit.
Past performance6/6
Return on equity over 15%
Return on equity was 19.8% over the last twelve months and averaged 15.7% over five years.
Return on capital over 10%
Return on invested capital was 12.2%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Universal Health Services's return on equity of 19.8% is above the Health Services median of 4.6%.
Earnings grew over 5 years
Net income grew 9.5% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 8.0% over the last twelve months, against a 5-year average of 6.7%.
Net margin above the industry
Universal Health Services's net margin of 8.0% is above the Health Services median of -2.6%.
Financial health3/6
High debt
Debt is 75.1% of shareholders' equity, above the 40% we consider low.
Debt rising against equity
Debt to equity rose from 61.0% five years ago to 75.1%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 36.0% of total debt.
Interest well covered
Operating income covers interest expense 11.3 times.
Short-term assets cover short-term debts
Current assets are 1.37 times current liabilities.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.25; above 3 is the safe zone and below 1.8 the distress zone.
Dividend4/6
Pays a dividend
Universal Health Services paid dividends worth 0.4% of the share price over the last twelve months.
Yield below Treasuries
The 0.4% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Universal Health Services yields 0.4%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 7 fiscal years.
Covered by earnings
Dividends take 3.3% of net income.
Covered by free cash flow
Dividends take 4.4% of free cash flow.
Fair value
How we estimate itOur estimate per share
$333.12
The share price is 41% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 17.6× | 11.4× | 23.9× | $421.32 | 40% |
| EV/EBITDA | 8.3× | 8.0× | 8.6× | $277.87 | 35% |
| P/B | 2.6× | 1.8× | 3.5× | $340.61 | 10% |
| Earnings power | 8.7% cost of equity | – | – | $221.88 | 15% |
| Fair value | $333.12 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 11.4
- Health Services median 23.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $128.42M
- Value traded per 1% price move
- $87.56M
Downside
Medium risk
- Typical loss in a bad month
- 18.3%
- Volatility (annualized)
- 34%
- Sharpe ratio, 1 year
- -0.47
- Beta to the S&P 500 (5Y)
- 0.77
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +9.7% | +9.0% | +8.5% | +6.7% | |
| Operating income | +18.6% | +25.7% | +8.0% | +4.7% | |
| Net income | +30.4% | +30.1% | +9.5% | +8.1% | |
| EPS, diluted | +37.3% | +36.2% | +16.0% | +13.1% | |
| Free cash flow | -24.4% | +48.0% | -12.2% | +2.1% | |
| Dividend per share | 0.0% | 0.0% | – | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 16.0% | 16.0% | 21.4% | |
| Return on assets | 7.0% | 7.5% | 9.9% | |
| Current ratio | 1.28 | 1.32 | 1.05 | |
| Debt to equity | 0.91 | 0.61 | 0.65 | |
| Net debt to EBITDA | 2.42× | 1.41× | 1.77× | |
| Interest coverage | 10.2× | 12.8× | 12.8× | |
| Capex to revenue | 5.3% | 6.3% | 5.8% | |
| Diluted shares | 98M | 86M | 64M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Universal Health Services generated $7.08B from operations and spent $8.82B on capital expenditure, dividends and share buybacks. 49% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 8.6% | 1.16× | 2.15× | 21.4% |
| FY2024 | 7.2% | 1.11× | 2.22× | 17.8% |
| FY2023 | 5.0% | 1.04× | 2.28× | 11.9% |
| FY2022 | 5.0% | 1.01× | 2.21× | 11.3% |
| FY2021 | 7.8% | 0.95× | 2.14× | 16.0% |
| FY2020 | 8.2% | 0.92× | 2.13× | 16.0% |
| FY2019 | 7.2% | 0.99× | 2.11× | 15.0% |
| FY2018 | 7.2% | 0.98× | 2.12× | 15.0% |
| FY2017 | 7.2% | 0.99× | 2.21× | 15.8% |
| FY2016 | 7.2% | 0.98× | 2.27× | 16.0% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$1.49B
- Cash generatingOperating cash flow above zero$1.86B
- Return on assets improvedROA up on the prior year8.2% → 10.3%
- Earnings backed by cashOperating cash flow above net income$1.86B vs $1.49B
- Less leverageLong-term debt to assets fell30.9% → 25.8%
- Better liquidityCurrent ratio rose1.27 → 1.05
- No dilutionShare count did not rise68M → 64M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose1.13 → 1.20
See a number that looks wrong?